Lucentis Vial

Lucentis (ranibizumab) is a prescription medication designed to treat various retinal conditions, including wet age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV). Administered as an intravitreal injection, Lucentis directly targets abnormal blood vessel growth and fluid leakage in the retina to preserve and improve vision.

Benefits:

• Slows vision loss in wet AMD
• Improves vision and reduces swelling in DME and RVO
• Directly targets abnormal blood vessel growth for precise treatment
• Proven to enhance vision in clinical studies
• Flexible dosing schedule based on patient needs

Dosage:

• For Wet Age-Related Macular Degeneration (AMD), administer 0.5 mg (0.05 mL) once a month (every 28 days)
• For Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO), administer 0.5 mg (0.05 mL) once a month
• For Myopic Choroidal Neovascularization (mCNV), administer 0.5 mg (0.05 mL) as a single injection
  Additional injections may be given if disease activity recurs, as determined by your healthcare provider
• Treatment frequency may be reduced after the first three months depending on individual response, with some patients transitioning to as-needed dosing

Warnings and Precautions:

• Not suitable for individuals with active eye infections
• May increase the risk of endophthalmitis (eye infection) or inflammation
• Patients with a history of stroke or heart conditions should use cautiously
• Inform your healthcare provider about allergies to ranibizumab or similar medications
• Avoid driving or operating machinery immediately after injections due to potential blurred vision

Usage Instructions:

• Administered only by a trained healthcare provider in a clinical setting
• Follow all follow-up appointments for regular injections
• Monitor for signs of infection, such as redness, pain, or vision changes, and report them immediately
• Do not rub or touch the treated eye after injection

Storage Information:

• Store vials in a refrigerator between 36°F and 46°F (2°C to 8°C)
• Keep in original packaging to protect from light exposure
• Do not freeze or reuse the vial once opened

Common Side Effects:

• Eye pain or discomfort at the injection site
• Temporary blurred vision or light sensitivity
• Increased intraocular pressure shortly after injection
• Rarely, serious conditions like retinal detachment or infection